6507-10-4

Basic information

• Product Name: 5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole
• Synonyms: 5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole
• CAS NO: 6507-10-4
• Molecular Formula: C14H13N3
• Molecular Weight: 223.27312
• Mol File: 6507-10-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 455.0±47.0 °C(Predicted)
• Appearance: /
• Density: 1.199±0.06 g/cm3(Predicted)
• PKA: 10.95±0.10(Predicted)
• CAS DataBase Reference: 5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole(6507-10-4)
• EPA Substance Registry System: 5,6-dimethyl-2-(pyridin-3-yl)-1H-benzo[d]imidazole(6507-10-4)

Safety Data

• Hazardous Substances Data: 6507-10-4(Hazardous Substances Data)

Upstream product

• 500-22-1 3-pyridinecarboxaldehyde 
• 3171-45-7 4,5-dimethyl-1,2-phenylenediamine 

Downstream Products

• 1535186-97-0 C₂₁H₁₅FN₄ 
• 1535187-21-3 C₂₁H₁₅FN₄ 

Relevant articles and documents

NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF

Novel soluble epoxide hydrolase (sEH) inhibitors are provided, along with methods for their use. The soluble epoxide hydrolase inhibitors are useful in treating and/or preventing sEH-related related diseases, such as Alzheimer's disease and inflammation.

Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines

A new series of dihydrofolate reductase (DHFR) inhibitors, the 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines, were designed and optimized for antibacterial potency and enzyme selectivity. The most potent inhibitors in this series contained a five-membered